Mereo BioPharma Group plc - American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share (MREO)

103 filings reported holding MREO - Mereo BioPharma Group plc - American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share as of Q4 2024.
Mereo BioPharma Group plc - American Depositary Shares, each representing five ordinary shares, nominal value of (pound)0.003 per share (MREO) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 115M shares of 795M outstanding shares and own 14.49% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (17.1M shares), Rubric Capital Management LP (15.3M shares), Rock Springs Capital Management LP (9.6M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (8.72M shares), MANGROVE PARTNERS IM, LLC (8.64M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6.71M shares), Frazier Life Sciences Management, L.P. (5.1M shares), ALKEON CAPITAL MANAGEMENT LLC (4.7M shares), 683 Capital Management, LLC (4.55M shares), and MILLENNIUM MANAGEMENT LLC (3.97M shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.